Showing results (1541-1550 of 5,932) with videos related to

Sort By:
Pageof 594
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
The Prostate|July 5, 2022
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysisDaniele Modonutti, Sami E Majdalany, Nicholas Corsi, et al.
The Prostate|January 1, 1986
Characterization of androgen receptors in normal and malignant human prostatic tissuesF Radwan, F Léger, M Carmel, et al.
The Prostate|June 2, 2022
PSA density is associated with BPH cellular compositionLiwei Jia, Douglas W Strand, Ramy S Goueli, et al.
The Prostate|June 24, 2022
The state of PSA counseling in male-to-female transgender patients in the U.SSiddharth Marthi, Timothy K O'Rourke, Christopher Tucci, et al.
The Prostate|January 4, 2021
Risk of major adverse cardiovascular events among second-line hormonal therapy for metastatic castration-resistant prostate cancer: A real-world evidence studyJui-Ming Liu, Cheng-Chia Lin, Miao-Fen Chen, et al.
The Prostate|December 22, 2022
Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluationIsabela Rossetto, Felipe Santos, Larissa Kido, et al.
The Prostate|May 31, 2017
Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancerKeiichiro Mori, Takahiro Kimura, Hajime Onuma, et al.
The Prostate|June 9, 2017
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network studyBerardino De Bari, Bradley Stish, Mark Wayne Ball, et al.
The Prostate|June 21, 2017
Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancerBing Cai, Wei Chen, Yue Pan, et al.
Pageof 594